India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of DirectorsBusiness Wire • 01/19/22
Clinical Trial on Alzheimer's Patients Indicates Positive Safety and Tolerability Data for IGC's THC-Based Investigational New DrugBusiness Wire • 12/14/21
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer's PatientsBusiness Wire • 12/08/21
Phase 1 Clinical Trial Data Indicate IGC's THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer's PatientsBusiness Wire • 12/02/21
IGC Posts Q2 Results, Reveals Promising Results From Clinical Trial Of THC-Drug For Alzheimer's SymptomsBenzinga • 11/01/21
IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and TolerabilityBusiness Wire • 09/07/21
India Globalization Capital Receives Patent To Treat Alzheimer's With Cannabis DrugSeeking Alpha • 07/24/21
An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising TreatmentsBenzinga • 07/23/21
India Globalization Capital Shares Skyrocket On Receiving Patent For THC Formula To Treat Alzheimer's DiseaseBenzinga • 07/22/21
IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THCBusiness Wire • 07/22/21
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer's PatientsBusiness Wire • 06/23/21
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's PatientsBusiness Wire • 06/08/21
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's PatientsBusiness Wire • 05/14/21